A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
Clinical trial NCT00001101 · COMPLETED
Trial details
- NCT number
- NCT00001101
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Primary completion
- 2001-03-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.